propranolol has been researched along with Rhabdomyosarcoma in 2 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Rhabdomyosarcoma: A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| " A cavernous hemangioma was suspected and treated with high doses of propranolol and prednisolone." | 7.85 | Unexpected Effect of Propranolol and Prednisolone on Infantile Facial Rhabdomyosarcoma. ( Bhandari, SB; Lemperle, G; Mentzel, T; Shakya, J; Shilpakar, R, 2017) |
| " A cavernous hemangioma was suspected and treated with high doses of propranolol and prednisolone." | 3.85 | Unexpected Effect of Propranolol and Prednisolone on Infantile Facial Rhabdomyosarcoma. ( Bhandari, SB; Lemperle, G; Mentzel, T; Shakya, J; Shilpakar, R, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| La Regina, G | 1 |
| Bai, R | 1 |
| Rensen, WM | 1 |
| Di Cesare, E | 1 |
| Coluccia, A | 1 |
| Piscitelli, F | 1 |
| Famiglini, V | 1 |
| Reggio, A | 1 |
| Nalli, M | 1 |
| Pelliccia, S | 1 |
| Da Pozzo, E | 1 |
| Costa, B | 1 |
| Granata, I | 1 |
| Porta, A | 1 |
| Maresca, B | 1 |
| Soriani, A | 1 |
| Iannitto, ML | 1 |
| Santoni, A | 1 |
| Li, J | 1 |
| Miranda Cona, M | 1 |
| Chen, F | 1 |
| Ni, Y | 1 |
| Brancale, A | 1 |
| Dondio, G | 1 |
| Vultaggio, S | 1 |
| Varasi, M | 1 |
| Mercurio, C | 1 |
| Martini, C | 1 |
| Hamel, E | 1 |
| Lavia, P | 1 |
| Novellino, E | 1 |
| Silvestri, R | 1 |
| Shilpakar, R | 1 |
| Lemperle, G | 1 |
| Mentzel, T | 1 |
| Shakya, J | 1 |
| Bhandari, SB | 1 |
2 other studies available for propranolol and Rhabdomyosarcoma
| Article | Year |
|---|---|
Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors.
Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyto | 2013 |
Unexpected Effect of Propranolol and Prednisolone on Infantile Facial Rhabdomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Diagnosis, Differential; Facial Neoplasms; F | 2017 |